Mahani Hamdan | Public Policy | Best Researcher Award

Posted on by Academic achievements

Assist Prof Dr . Mahani Hamdan | Public Policy | Best Researcher Award 

Senior Assistant Professor , Universiti Brunei Darussalam , Brunei Darrussalam .

Dr. Mahani Haji Hamdan is a Senior Assistant Professor at the Universiti Brunei Darussalam (UBD), specializing in Accounting and Finance. She holds various administrative roles, including Director of the Institute of Policy Studies. Her academic career spans over two decades, beginning as a Tutor and progressing to senior academic and leadership positions. Dr. Mahani has made significant contributions in public policy, corporate social reporting, and financial management research. In addition to her academic commitments, she actively engages in community services, such as consulting for Brunei’s public and private sectors. Her exemplary leadership and dedication to her field are reflected in her numerous awards and recognitions.

Profile

Scopus

Education

Dr. Mahani completed her Ph.D. in Management from Queensland University of Technology, Australia, in 2011. She also holds a Master’s degree in Accounting and Finance from the University of Leeds, and a BA (Hons) in Accounting & Financial Management from the University of Sheffield, United Kingdom. She further enriched her academic journey through a Post-Doctoral Fellowship at the prestigious Goldman School of Public Policy, University of California, Berkeley, USA, in 2015. Throughout her educational pursuits, Dr. Mahani has earned several accolades, including the Certificate of Best Research Higher Degree Student Award, demonstrating her commitment to academic excellence.

Experience

Dr. Mahani began her career in finance as an Accounting Officer at the Employees’ Trust Fund, Ministry of Finance, Brunei, and later transitioned into academia. She joined Universiti Brunei Darussalam in 2004 as a Lecturer and steadily rose through the ranks to her current position as Senior Assistant Professor. Her leadership extends to roles such as Director of the Institute of Policy Studies and previously, Deputy Dean of UBD’s School of Business and Economics. In addition to teaching, she leads various research initiatives in public policy, finance, and management.

Awards and Honors

Dr. Mahani has been recognized with numerous awards throughout her career. In 1990, she was awarded the Best Student Award by Brunei SHELL. In 2010, she received the Certificate of Best Research Higher Degree Student Award from the Queensland University of Technology, Australia. Most recently, in 2024, Dr. Mahani was honored with the Outstanding Paper Award at the Emerald Awards for her research contributions. Her dedication to excellence in research and education has consistently earned her recognition in both national and international academic communities.

Research Focus

Dr. Mahani’s research interests include budgeting practices for SMEs, the adoption of International Accounting Standards (IAS), and public policy analysis in Brunei. She also explores performance management systems and corporate social reporting in relation to organizational justice. Additionally, she investigates sovereign wealth management and sustainable development policies. Her research often bridges the gap between theoretical frameworks and practical implementations, particularly in the public and private sectors of Brunei.

Publications

  • “Post-Crisis Emerging Role of the Treasurer”
  • “Is Brunei Ready to Adopt the International Accounting System?”
  • “Sovereign Wealth Funds and Wealth Management in Brunei Darussalam”
  • “Transformational Change in Brunei Higher Education”
  • “Electricity Tariff Reforms, Welfare Impacts, and Energy Poverty Implications”
  • “Working from Home, Covid-19, and Multi-Dimensional Model of Well-Being Theory”

Conclusion

Dr. Mahani Haji Hamdan is a strong candidate for the Best Researcher Award due to her diverse academic expertise, leadership roles, and mentorship capabilities. Her experience in research across various disciplines and her contributions to public policy, supported by numerous awards and grants, position her as a leading figure in her field. To further strengthen her candidacy, increased international collaboration and more publications in top-tier journals may be beneficial.

Anke van Engen | Policy | Best Researcher Award

Posted on by Academic achievements

Mrs. Anke van Engen | Policy | Best Researcher Award 

Managing Principal , IQVIA , Netherlands

Anke van Engen is an accomplished professional with over 20 years of experience in global health economics, outcomes research, and market access. As the Managing Principal at IQVIA Payer Evidence Solutions in Amsterdam, she is dedicated to maximizing the commercial success of life sciences products through integrated payer evidence strategies. Anke excels in building long-lasting client partnerships and is highly respected for her expertise and collaborative approach. She leads an international team of consultants, guiding them to success with her strategic planning and leadership skills.

Profile

Scopus

Strengths for the Award

  • Extensive Experience: Anke van Engen brings over 20 years of global experience in health economics, outcomes research, and market access. This depth of expertise makes her a formidable candidate for the award.
  • Proven Leadership: Her ability to lead international teams, manage significant P&L responsibilities, and develop innovative strategies has resulted in commercial successes for life sciences companies.
  • Innovation and Thought Leadership: Anke has led the development of key market access tools like the HTA Accelerator platform, demonstrating her capacity for innovation. Her numerous awards and published works further solidify her thought leadership in the field.
  • Client-Centric Approach: Known for building long-lasting partnerships and being a trusted advisor, she has a strong track record of delivering consistent results to clients.
  • Recognition in the Field: Anke’s participation in high-profile panels and her awards, including ISPOR Best Podium and Poster Awards, highlight her respect and recognition within the industry.

Areas for Improvement

  • Broader Academic Contributions: While Anke has published extensively and contributed to industry thought leadership, increasing her involvement in academic research or university collaborations could enhance her profile in the academic community.
  • Further Expansion of Strategic Influence: Expanding her strategic influence beyond Europe and into more global markets, especially emerging ones, could showcase her ability to adapt and innovate in diverse environments.

Anke van Engen is an accomplished professional with over 20 years of experience in global health economics, outcomes research, and market access. As the Managing Principal at IQVIA Payer Evidence Solutions in Amsterdam, she is dedicated to maximizing the commercial success of life sciences products through integrated payer evidence strategies. Anke excels in building long-lasting client partnerships and is highly respected for her expertise and collaborative approach. She leads an international team of consultants, guiding them to success with her strategic planning and leadership skills.

Education

MSc Chemistry from the University of Leiden, the Netherlands (1994-1999), specializing in Bio-organic Chemistry. Anke also pursued an internship in biochemistry at the Institute of Fundamental Sciences, Massey University, New Zealand. Additionally, she completed advanced training programs in strategic leadership and health economic evaluation from the International Institute for Management Development and the University of Oxford, respectively.

Experience

Managing Principal, IQVIA Payer Evidence Solutions (2023-present): Leading a cluster within the EMEA Real World Evidence Leadership Team, Anke shares P&L responsibility and spearheads the integration of evidence and EU HTA offerings.
Senior Principal, IQVIA Real World Solutions (2020-2023): Directed the development of EMEA-specific offerings and played a crucial role in go-to-market strategies and client partnerships.
Senior Principal, IQVIA Consulting Services (2017-2020): Partnered with pharmaceutical companies, led global HTA solutions, and provided strategic oversight.
Principal, Quintiles Advisory Services (2014-2017): Developed and marketed the flagship HTA Accelerator product and led HEOR/MA strategy and implementation projects.
Consulting Director, Quintiles Consulting (2012-2014): Managed strategy consulting projects for pharmaceutical and medical device companies across Europe, with a focus on market access and health economic modeling.

Research Interest

Health Economics & Market Access: Anke’s research interests focus on developing and implementing health economic models, market access strategies, and health technology assessment (HTA). She has contributed significantly to thought leadership in payer evidence strategy, emphasizing the importance of integrating payer insights for successful product launches.

Awards

Issue Panel Recognition: Anke’s issue panel “EU Joint Clinical Assessment – One for All and All for One?” was ranked as the top-attended session at ISPOR Europe 2023.
Best Innovation Award (2014): Won the Sharktank contest for best innovation and secured investment for the HTA Accelerator platform.
ISPOR Awards: Received multiple ISPOR Best Podium and Poster Awards for her contributions to understanding the complexity of HTA networks and for her health economic analysis work.

Publications

The Impact of Additive PICOs in a European Union Joint Clinical Health Technology Assessment (2024). Value Health (Accepted for publication).
Use of External Comparators for Health Technology Assessment (HTA) Submissions Based on Single-Arm Trials (2021). Value Health, 24(8):1118-25.
Call in the PROs: Giving Credence to the Patient’s Perspective in Healthcare Decision Making (2020). ISPOR Value & Outcomes Spotlight.
Use of Insertable Cardiac Monitors for the Detection of Atrial Fibrillation in Patients with Cryptogenic Stroke in the United States is Cost-effective (2019). Journal of Medical Economics.
How Can Payer Requirements Be Satisfied when Treatment Switching Occurs? (2016). ISPOR Value & Outcomes Spotlight.
Economic Evaluation of Fidaxomicin for the Treatment of Clostridium difficile Infection in Ireland (2015). JHEOR, 2(2):192-206.
Cost-effectiveness of a Fixed-dose Combination of Solifenacin and Oral Controlled Adsorption System Formulation of Tamsulosin in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia (2015). BMC Urology, 15(1):41.

Conclusion

Anke van Engen is a highly suitable candidate for the Best Researcher Award. Her extensive experience, leadership, and innovative contributions to health economics and market access make her a strong contender. With a few strategic expansions in her academic involvement and global reach, she could further solidify her candidacy for such prestigious recognition.